Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
Funding for transnational projects on Antimicrobial Resistance |
Característiques principals
This call advocates for a One Health approach. Proposals should focus on at least two One Health settings (human, animal, environment) and should aim to either: OR |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.1670 |
Convocatòria (URL)
https://www.jpiamr.eu/activities/joint-calls/open-calls/interventions-and-transmission-call-2021/ Submission Tool: https://ptoutline.eu/app/jpiamr2021_harissa |
Informació addicional
The call follows a two-stage procedure: |
Requisits
The consortium must include a minimum of three (3) eligible partners asking for funding from three (3) different countries (at least two from EU Member States or AssociatedCountries5). Maximum of six (6) project partners (including non-funded partners).The maximum number of partners can be increased to seven (7) if partners from underrepresented countries (including LMICs7) are included in the consortium. Please consult the call text for detailed eligibility requirements. |
Dotació
Up to €175,000/€250,000 for partners/coordinators |
Durada
Up to 36 months. |
AVÍS IMPORTANT
The call is made at European level but each partner of the consortium is funded by its national funding agency and must follow its national funding rules. Spanish participants are funded by ISCIII. There are eligibility requirements for the institutions and principal investigators funded by ISCIII. (please see annex B of the Call text). Due to the complexity of the call, if you are interested in submitting an application we strongly recommend that you contact the Servei de Recerca well in advance of the deadline. |
Arxius
Arxiu |
---|
Call-Text_JPIAMR-13th-Call_v210114.pdf |
Pre-proposal-form_JPIAMR-13th-call_v.210114.docx |